BAPTIST HEALTH LEXINGTON
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $12.8M
- Transactions
- 3,696
- Companies
- 40
- Average per transaction
- $3,472
Who reported the payments
| AstraZeneca | $1,910,379 |
| Merck | $1,219,582 |
| E.r. Squibb & Sons, L.L.C. | $863,754 |
| Beigene, Ltd. | $829,858 |
| Boston Scientific | $722,768 |
| EMD Serono, Inc. | $582,409 |
| Abbott | $556,821 |
| Genentech, Inc. | $489,419 |
| Stryker | $411,816 |
| Tolmar, Inc. | $392,455 |
| Acutus Medical, Inc. | $309,938 |
| Biosense Webster, Inc. | $294,569 |
| Gilead | $280,439 |
| Novartis | $273,980 |
| Incyte Corporation | $271,149 |
| Daiichi Sankyo Inc. | $270,615 |
| Hologic Inc | $218,526 |
| Medical Device Business Services, Inc. | $200,746 |
| AbbVie | $167,408 |
| Biotronik Inc. | $162,384 |
| Intuitive Surgical | $160,970 |
| Mirati Therapeutics, Inc. | $146,801 |
| Biogen | $144,893 |
| Lantheus Medical Imaging, Inc. | $133,080 |
| Impulse Dynamics (USA) Inc. | $123,943 |
| Medtronic | $123,755 |
| Beone Medicines Ltd. | $116,884 |
| Sanofi | $97,627 |
| Cvrx, Inc. | $92,049 |
| ZOLL Respicardia, Inc. | $71,015 |
| Astrazeneca UK Limited | $70,656 |
| Inari Medical, Inc. | $66,604 |
| Bristol Myers Squibb | $62,688 |
| Eli Lilly | $62,528 |
| Gentuity, LLC | $61,052 |
| Beone Medicines USA, Inc. | $57,654 |
| Roche Products Limited | $54,708 |
| Route 92 Medical, Inc. | $54,217 |
| Microvention, Inc. | $51,230 |
| Beigene USA, Inc. | $49,486 |